Orthopediatrics CORP Form 4 insider transactions

OrthoPediatrics' COO and CFO, Fred Hite, purchased 5,076 shares but disgorged $27,664.20 due to a short-swing profit violation.

Orthopediatrics Corp. Director Bryan W. Hughes has acquired 8,401 shares of common stock at a price of $0, increasing his total beneficial ownership to 21,227 shares, including restricted stock awards.

ORTHOPEDIATRICS Corp. Director Marie C. Infante (Reynolds) reported the acquisition of 8,401 shares of common stock on May 23, 2025, increasing her total beneficial ownership to 19,766 shares.

Orthopediatrics Corp. Director Harold Ruf has increased his beneficial ownership in the company by receiving 8,401 shares of common stock as a restricted stock award.

Orthopediatrics Corp. Director Terry D. Schlotterback reported the acquisition of 8,401 shares of common stock, increasing his direct beneficial ownership to 26,619 shares, including restricted stock awards.

ORTHOPEDIATRICS Corp. Director Jimmy Duane McDonald acquired 8,401 shares of common stock on May 23, 2025, increasing his direct beneficial ownership to 13,132 shares.

George Sinclair Mitchell Dyer, a Director and 10% Owner of ORTHOPEDIATRICS CORP, acquired 8,401 shares of common stock on May 23, 2025, increasing his total beneficial ownership to 13,132 shares.

ORTHOPEDIATRICS Corp. Director and 10% Owner David R. Pelizzon acquired 8,401 shares of common stock on May 23, 2025, increasing his direct beneficial ownership to 32,948 shares.

Orthopediatrics Corp. Director Samuel D. Riccitelli has increased his beneficial ownership in the company by acquiring 8,401 shares of common stock through a restricted stock award on May 23, 2025.

Orthopediatrics Corp. Director Mark C. Throdahl has acquired 8,401 shares of common stock, increasing his direct beneficial ownership to 167,881 shares, including restricted stock awards.

Daniel J. Gerritzen, General Counsel and Secretary of Orthopediatrics Corp., sold shares to cover tax withholding obligations upon the vesting of restricted shares.

David R. Bailey, CEO of Orthopediatrics Corp, reports acquisition and disposal of company stock, including sales to cover tax obligations.

Fred Hite, COO and CFO of Orthopediatrics Corp., reports acquisition of shares via vesting and disposition of shares to cover tax obligations.

Gregory A. Odle, President of Scoliosis at Orthopediatrics Corp., reports acquisition and disposal of company stock on March 15 and 18, 2025.

Joseph W. Hauser, an officer at Orthopediatrics Corp, reports acquisition and disposal of company stock, including shares to cover tax obligations.

OrthoPediatrics Corp. CEO David R. Bailey reported a gift of 1,500 common stock shares, with no monetary transaction involved, on December 27, 2024.

Daniel J. Gerritzen, General Counsel and Secretary of Orthopediatrics Corp., sold 10,000 shares of common stock on August 21, 2024.

Daniel J. Gerritzen, General Counsel and Secretary of Orthopediatrics Corp., reports acquisition of shares.

Joseph W. Hauser, an officer at Orthopediatrics Corp, acquired 37,936 shares of common stock on June 11, 2024.

Director Mark C. Throdahl reports acquiring 21,623 shares of Orthopediatrics Corp. common stock on June 11, 2024.

Gregory A. Odle, President of Scoliosis at Orthopediatrics Corp., reports acquiring 34,901 shares of common stock on June 11, 2024.

Fred Hite, COO and CFO of Orthopediatrics Corp., reports the acquisition of 57,018 shares of common stock on June 11, 2024.

Orthopediatrics Corp.'s CEO, David R. Bailey, acquired 90,395 shares of common stock on June 11, 2024.

Director Ruf Harold reported gifting 2,766 shares of Orthopediatrics Corp common stock to The Last Chance Legacy Trust.

Director Harold Ruf reports gifting of Orthopediatrics Corp. stock and holdings in a Roth IRA.

Director Jimmy Duane McDonald acquired 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.

Director Ruf Harold reports acquiring 2,766 shares of Orthopediatrics Corp. common stock on May 28, 2024.

Director Marie C Infante reports acquiring 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.

Director Samuel D. Riccitelli acquired 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.

Director George Sinclair Mitchell Dyer acquired 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.